PHOENIX — Gene therapy could be the key to curing rare and life-threatening diseases, but high costs and potential negative effects are slowing the fledgling field, experts say. In gene therapy, normal genetic material replaces missing or defective genes to cure disease. In December, the Food and Drug Administration approved Luxturna, the first commercial gene […]
